These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33121874)

  • 41. LAIR-1 agonism as a therapy for acute myeloid leukemia.
    Lovewell RR; Hong J; Kundu S; Fielder CM; Hu Q; Kim KW; Ramsey HE; Gorska AE; Fuller LS; Tian L; Kothari P; Paucarmayta A; Mason EF; Meza I; Manzanarez Y; Bosiacki J; Maloveste K; Mitchell N; Barbu EA; Morawski A; Maloveste S; Cusumano Z; Patel SJ; Savona MR; Langermann S; Myint H; Flies DB; Kim TK
    J Clin Invest; 2023 Nov; 133(22):. PubMed ID: 37966113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting the Leukemic stem cell protein machinery by inhibition of mitochondrial pyrimidine synthesis.
    Donato E; Trumpp A
    EMBO Mol Med; 2022 Jul; 14(7):e16171. PubMed ID: 35694783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation.
    Qi J; Singh S; Hua WK; Cai Q; Chao SW; Li L; Liu H; Ho Y; McDonald T; Lin A; Marcucci G; Bhatia R; Huang WJ; Chang CI; Kuo YH
    Cell Stem Cell; 2015 Nov; 17(5):597-610. PubMed ID: 26387755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination.
    Pallarès V; Unzueta U; Falgàs A; Sánchez-García L; Serna N; Gallardo A; Morris GA; Alba-Castellón L; Álamo P; Sierra J; Villaverde A; Vázquez E; Casanova I; Mangues R
    J Hematol Oncol; 2020 Apr; 13(1):36. PubMed ID: 32295630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can we selectively target AML stem cells?
    Jordan CT
    Best Pract Res Clin Haematol; 2019 Dec; 32(4):101100. PubMed ID: 31779978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. AMPK-ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells.
    Jang JE; Eom JI; Jeung HK; Cheong JW; Lee JY; Kim JS; Min YH
    Clin Cancer Res; 2017 Jun; 23(11):2781-2794. PubMed ID: 27864418
    [No Abstract]   [Full Text] [Related]  

  • 48. Aberrant Lipid Metabolic Signatures in Acute Myeloid Leukemia.
    Singh P; Murali R; Shanmugam SG; Thomas S; Scott J; Warrier S; Arfuso F; Dharmarajan A; Gandhirajan RK
    Stem Cells; 2024 Mar; 42(3):200-215. PubMed ID: 38167958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Mitochondrial metabolism in AML cells].
    Tabe Y
    Rinsho Ketsueki; 2024; 65(9):961-966. PubMed ID: 39358296
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxidative stress is two-sided in the treatment of acute myeloid leukemia.
    Fan C; Yang X; Yan L; Shi Z
    Cancer Med; 2024 May; 13(9):e6806. PubMed ID: 38715546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL.
    Bauer K; Hauswirth A; Gleixner KV; Greiner G; Thaler J; Bettelheim P; Filik Y; Koller E; Hoermann G; Staber PB; Sperr WR; Keil F; Valent P
    Am J Hematol; 2024 Sep; 99(9):1721-1731. PubMed ID: 38822666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia.
    Ghosh J; Kapur R
    Exp Hematol; 2017 Jun; 50():13-21. PubMed ID: 28342808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
    Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B
    Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Leukemia Stem Cells Phenotype Expression on Response to Induction Therapy in Acute Myeloid Leukemia Patients.
    Almohsen F; Al-Mudallal SS
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(2):145-151. PubMed ID: 31438833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [New approaches to target leukemia stem cells].
    Takenaka K; Akashi K
    Nihon Rinsho; 2014 Jun; 72(6):1018-25. PubMed ID: 25016798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia.
    Gluexam T; Grandits AM; Schlerka A; Nguyen CH; Etzler J; Finkes T; Fuchs M; Scheid C; Heller G; Hackl H; Harrer N; Sill H; Koller E; Stoiber D; Sommergruber W; Wieser R
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation.
    Ma J; Liu B; Yu D; Zuo Y; Cai R; Yang J; Cheng J
    Br J Haematol; 2019 Oct; 187(1):49-64. PubMed ID: 31236919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II.
    Jones CL; Stevens BM; D'Alessandro A; Culp-Hill R; Reisz JA; Pei S; Gustafson A; Khan N; DeGregori J; Pollyea DA; Jordan CT
    Blood; 2019 Jul; 134(4):389-394. PubMed ID: 31101624
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Progress in the studies of acute myelogenous leukemia stem cell].
    Cui JW; Zhang XM; Wang GJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):549-52. PubMed ID: 14575558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
    Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
    Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.